Clinical study of Weierkang pills combined with triple therapy for Helicobacter pylori infectio
- Conditions
- Heilicobacter pylori infection
- Registration Number
- ITMCTR2000003109
- Lead Sponsor
- Department of Gastroenterology, Run Run Shaw Hospital of Zhejiang University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
1. Voluntarily sign the informed consent;
2. The age is more than 18 years old, men and women are not limited;
3. Patients who were Hp positive without anti-bacterial treatment;
1. Patients who have used antibiotics or bismuth agent within 4 weeks; Patients who had used antacids (H2 antagonists or proton pump inhibitors), prokinetic drugs (mosapride or doperidone, etc.) and gastric mucosa protectants (tipredone, sucralose, rabapet, etc.) in the previous 2 weeks;
2. Patients with serious lesions in important organs of the body (heart, liver, kidney, lung, etc.);
3. Patients diagnosed with gastric cancer by gastroscopy or other examinations;
4. Pregnant and nursing women;
5. Unable to follow visitors or allergic to this study.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method